97 related articles for article (PubMed ID: 16452696)
21. Veterans who may need a payee to prevent misuse of funds for drugs.
Rosen MI; Rosenheck RA; Shaner A; Eckman T; Gamache G; Krebs C
Psychiatr Serv; 2002 Aug; 53(8):995-1000. PubMed ID: 12161675
[TBL] [Abstract][Full Text] [Related]
22. Representative payee practices of community mental health centers in Washington State.
Ries RK; Dyck DG
Psychiatr Serv; 1997 Jun; 48(6):811-4. PubMed ID: 9175191
[TBL] [Abstract][Full Text] [Related]
23. Barriers to physical and mental condition integrated service delivery.
Kathol RG; Butler M; McAlpine DD; Kane RL
Psychosom Med; 2010 Jul; 72(6):511-8. PubMed ID: 20498293
[TBL] [Abstract][Full Text] [Related]
24. Results of a multisite randomized trial of supported employment interventions for individuals with severe mental illness.
Cook JA; Leff HS; Blyler CR; Gold PB; Goldberg RW; Mueser KT; Toprac MG; McFarlane WR; Shafer MS; Blankertz LE; Dudek K; Razzano LA; Grey DD; Burke-Miller J
Arch Gen Psychiatry; 2005 May; 62(5):505-12. PubMed ID: 15867103
[TBL] [Abstract][Full Text] [Related]
25. Veterans Affairs Intensive Case Management for older veterans.
Mohamed S; Neale MS; Rosenheck R
Am J Geriatr Psychiatry; 2009 Aug; 17(8):671-81. PubMed ID: 19625784
[TBL] [Abstract][Full Text] [Related]
26. A longitudinal perspective on monitoring outcomes of an innovative program.
Rosenheck RA; Seibyl CL
Psychiatr Serv; 2005 Mar; 56(3):301-7. PubMed ID: 15746504
[TBL] [Abstract][Full Text] [Related]
27. Treatment setting and baseline substance use severity interact to predict patients' outcomes.
Tiet QQ; Ilgen MA; Byrnes HF; Harris AH; Finney JW
Addiction; 2007 Mar; 102(3):432-40. PubMed ID: 17298651
[TBL] [Abstract][Full Text] [Related]
28. Representative payeeship and mental illness: a review.
Luchins DJ; Roberts DL; Hanrahan P
Adm Policy Ment Health; 2003 Mar; 30(4):341-53. PubMed ID: 12870559
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic limit setting in an assertive community treatment program.
Neale MS; Rosenheck RA
Psychiatr Serv; 2000 Apr; 51(4):499-505. PubMed ID: 10737826
[TBL] [Abstract][Full Text] [Related]
30. A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions.
Battersby MW; Beattie J; Pols RG; Smith DP; Condon J; Blunden S
Aust N Z J Psychiatry; 2013 May; 47(5):451-62. PubMed ID: 23307806
[TBL] [Abstract][Full Text] [Related]
31. Long-term effectiveness and cost of a systematic care program for bipolar disorder.
Simon GE; Ludman EJ; Bauer MS; Unützer J; Operskalski B
Arch Gen Psychiatry; 2006 May; 63(5):500-8. PubMed ID: 16651507
[TBL] [Abstract][Full Text] [Related]
32. Use of leverage to improve adherence to psychiatric treatment in the community.
Monahan J; Redlich AD; Swanson J; Robbins PC; Appelbaum PS; Petrila J; Steadman HJ; Swartz M; Angell B; McNiel DE
Psychiatr Serv; 2005 Jan; 56(1):37-44. PubMed ID: 15637190
[TBL] [Abstract][Full Text] [Related]
33. Financial Capability: Clinicians' Assessment of Beneficiaries With Dual Diagnoses.
Thornhill Iv TA; Black AC; Rosen MI
J Dual Diagn; 2018; 14(2):130-136. PubMed ID: 29505348
[TBL] [Abstract][Full Text] [Related]
34. Substance use and assignment of representative payees.
Rosen MI; Rosenheck R
Psychiatr Serv; 1999 Jan; 50(1):95-8. PubMed ID: 9890587
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of managing disability benefits among patients with substance dependence and severe mental illness.
Ries RK; Dyck DG; Short R; Srebnik D; Fisher A; Comtois KA
Psychiatr Serv; 2004 Apr; 55(4):445-7. PubMed ID: 15067161
[TBL] [Abstract][Full Text] [Related]
36. Effect of managed care on access to mental health services among Medicaid enrollees receiving substance treatment.
Bigelow DA; McFarland BH; McCamant LE; Deck DD; Gabriel RM
Psychiatr Serv; 2004 Jul; 55(7):775-9. PubMed ID: 15232016
[TBL] [Abstract][Full Text] [Related]
37. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
Rothbard AB; Lee S; Blank MB
J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
[TBL] [Abstract][Full Text] [Related]
38. Disability payments, drug use and representative payees: an analysis of the relationships.
Swartz JA; Hsieh CM; Baumohl J
Addiction; 2003 Jul; 98(7):965-75. PubMed ID: 12814502
[TBL] [Abstract][Full Text] [Related]
39. A peer-support, group intervention to reduce substance use and criminality among persons with severe mental illness.
Rowe M; Bellamy C; Baranoski M; Wieland M; O'Connell MJ; Benedict P; Davidson L; Buchanan J; Sells D
Psychiatr Serv; 2007 Jul; 58(7):955-61. PubMed ID: 17602012
[TBL] [Abstract][Full Text] [Related]
40. A randomized controlled trial of illness management and recovery with an active control group.
Salyers MP; McGuire AB; Kukla M; Fukui S; Lysaker PH; Mueser KT
Psychiatr Serv; 2014 Aug; 65(8):1005-11. PubMed ID: 24733680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
